phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Coronary Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanson, SR; Harker, LA; King, SB; Nunes, GL; Scott, NA | 1 |
| Hanson, SR; King, SB; Nunes, GL; Sahatjian, RA; Scott, NA | 1 |
2 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Coronary Thrombosis
| Article | Year |
|---|---|
Local delivery of an antithrombin inhibits platelet-dependent thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antithrombins; Blood Platelets; Blood Vessel Prosthesis; Coronary Thrombosis; Dose-Response Relationship, Drug; Hemostasis; Injections, Intravenous; Polyethylene Terephthalates; Swine | 1994 |
Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Angioplasty, Balloon; Animals; Antithrombins; Blood Platelets; Catheterization; Coronary Thrombosis; Drug Delivery Systems; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections, Intravenous; Polyethylene Glycols; Swine | 1994 |